摘要
目的:标定Rh D(Ig M)血型定型试剂(单克隆抗体)国家参考品。方法:对Rh D(Ig M)血型定型试剂(单克隆抗体)原料进行分装冻干及复溶时间和水分检测,复溶后对效价开展协作标定,并进行了稳定性检测。结果:Rh D(Ig M)血型定型试剂参考品的复溶时间、水分均符合2010年版中国药典标准。标定效价为国际参考品的1.2倍。结论:该批Rh D(Ig M)血型定型试剂各项指标均符合要求,可作为国家参考品使用;将该参考品稀释至3.6倍可达到WHO推荐的最小效价要求。
Objective: To calibrate national reference substances for RhD ( IgM ) blood grouping reagents ( monoclonal antibodies ). Methods : RhD ( IgM ) blood grouping reagents ( monoclonal antibodies ) were calibrated in a collaborative study after dispersal, lyophilization, reconstitute time and moisture content testing. Stability of the reagents was also examined. Results: Reconstitute time and moisture content of these reagents conformed to the requirements of ChP 2010, Vol ]I[ Calibrated titer of the national reference substance was 1.2 times of the international reference substance. Conclusion: The RhD ( IgM ) blood grouping reagents ( monoclonal antibodies ) could be used as national reference substances. The reference substances of 3.6-fold dilution could meet the minimum potencies standards of RhD ( IgM ) blood grouping reagents recommended by WHO.
出处
《药物分析杂志》
CAS
CSCD
北大核心
2016年第1期162-164,共3页
Chinese Journal of Pharmaceutical Analysis
基金
国家863课题"新型体外诊断试剂质量评价体系和国家参考物质研究"(2011AA02A115)
关键词
RH血型系统
血型定型试剂
单克隆抗体
参考品
效价
协作标定
Rh blood grouping system
blood grouping reagents
monoclonal antibodies
reference substance
potency
collaborative specification